Lidocaine arthritis topical product recalled due to improper storage
Family Dollar Stores is recalling Lidocaine Arthritis and Sport wintergreen liniment (16 fl oz, SKU 902929) distributed nationwide April 30–June 10, 2022, due to improper storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II FDA drug recall for a CGMP violation involving improper storage temperature. No illnesses, injuries, or hospitalizations have been reported. The deviation represents a manufacturing and compliance issue rather than an acute safety threat.
Plain-English summary
Family Dollar Stores, LLC, is recalling Lidocaine Arthritis and Sport wintergreen liniment in 16 fl oz bottles (SKU 902929). The affected product was distributed to specific Family Dollar Stores nationwide during the period of April 30, 2022, through June 10, 2022.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the product was held outside appropriate storage temperature conditions during distribution.
Consumers who obtained this product can identify it by SKU 902929. For specific information regarding this recall, including return and refund procedures, consumers should contact Family Dollar Stores or the FDA.
The recalled product
- Product
- LIDOCAINE ARTHRITIS AND SPORT WNTGRN 16 FLOZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical Analgesic
- Hazard
- improper-storage
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902929
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01